Marla C. Dubinsky
0000-0003-4968-5795
Publication & Citation Trends
Publications
890 total
Immunometabolism as a New Bimodal Therapeutic Concept in Inflammatory Bowel Disease and Immune-Mediated Inflammatory Disorders.
Cited by 1
Semantic Scholar
P1077 Impact of baseline body mass index (BMI) on efficacy of obefazimod in patients with moderately to severely active ulcerative colitis: results from the Phase 3 ABTECT induction trials
Cited by 0
Semantic Scholar
P0804 Impact of prior inadequate response to advanced therapies on early symptomatic improvement with obefazimod induction in moderately to severely active ulcerative colitis: results from the two Phase 3 placebo-controlled ABTECT induction trials
Cited by 0
Semantic Scholar
Upadacitinib Maintenance Therapy in Pediatric Ulcerative Colitis: 52-week Multicenter Study from the Porto Group of ESPGHAN.
Cited by 0
Semantic Scholar
P0959 Upadacitinib for maintenance treatment in pediatric Crohn’s disease: 52-week outcomes of an international multicenter retrospective study from the pediatric IBD Porto group of ESPGHAN
Cited by 0
Semantic Scholar
Evaluating treatment to a target of transmural healing in patients with moderately to severely active Crohn’s disease: rationale, design and protocol for the randomised controlled VECTORS trial
Cited by 0
Semantic Scholar
INCIDENCE OF EXTRAINTESTINAL MANIFESTATIONS IN IBD PATIENTS TREATED WITH ADVANCED THERAPIES
Cited by 0
Semantic Scholar
Recovery of response and long-term outcomes following loss of response and dose escalation of subcutaneous infliximab: a post hoc analysis of the LIBERTY-CD & LIBERTY-UC trials.
Cited by 0
Semantic Scholar
Research Topics
Inflammatory Bowel Disease
(620)
Microscopic Colitis
(375)
Eosinophilic Esophagitis
(136)
Immunodeficiency and Autoimmune Disorders
(95)
Pregnancy and Medication Impact
(86)
Affiliations
Roche (Switzerland)
Cedars-Sinai Medical Center
Prisma Health
Dartmouth–Hitchcock Medical Center
Mount Sinai Health System